Detalhe da pesquisa
1.
Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC).
Int J Mol Sci
; 24(13)2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445722
2.
Correction to: Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.
Mol Cancer
; 19(1): 16, 2020 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31987050
3.
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples.
J Transl Med
; 18(1): 99, 2020 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32087721
4.
Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines.
Cell Immunol
; 319: 35-42, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28735814
5.
Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo.
BMC Cancer
; 16: 707, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27586635
6.
Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer.
Biochim Biophys Acta
; 1842(5): 747-55, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24480048
7.
Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.
Mol Cancer
; 14: 45, 2015 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25889301
8.
Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.
Eur Respir J
; 46(6): 1762-72, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26541534
9.
Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer.
Cancers (Basel)
; 15(6)2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980522
10.
PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer.
J Pathol
; 224(4): 564-74, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21706479
11.
Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer.
Mol Cancer
; 10: 25, 2011 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-21388528
12.
Prostacyclin synthase expression and epigenetic regulation in nonsmall cell lung cancer.
Cancer
; 117(22): 5121-32, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21523772
13.
Vaping and lung cancer - A review of current data and recommendations.
Lung Cancer
; 153: 11-20, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33429159
14.
Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC.
Cancers (Basel)
; 13(9)2021 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33946744
15.
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.
Clin Cancer Res
; 27(3): 807-818, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33122343
16.
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
Signal Transduct Target Ther
; 5(1): 7, 2020 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32296034
17.
Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer.
Pharmacol Ther
; 207: 107454, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31836451
18.
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Sci Rep
; 10(1): 14380, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32873828
19.
Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Sci Rep
; 10(1): 19870, 2020 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33177621
20.
Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells.
Cancers (Basel)
; 11(4)2019 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30999598